
Zimmer Biomet Holdings Inc (ZBH:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends
Description
Zimmer Biomet Holdings Inc (ZBH:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends
Report Summary
Zimmer Biomet Holdings Inc (ZBH:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends Report is a comprehensive and easily accessible overview of Zimmer Biomet Holdings Inc's business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about Zimmer Biomet Holdings Inc including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses Zimmer Biomet Holdings Inc's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. The PESTLE analysis evaluates the external factors impacting the company's operations and market environment. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Zimmer Biomet Holdings Inc's overall strategic standing and supports informed decision-making and strategic planning.
The report also covers Zimmer Biomet Holdings Inc's financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Zimmer Biomet Holdings Inc's financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.
Finally, the report includes recent news and deal activities undertaken by Zimmer Biomet Holdings Inc enhancing awareness of the company's business trends, growth perspectives, and more.
Key Highlights
Zimmer Biomet Holdings, Inc., along with its subsidiaries, operates globally as a medical technology company. The company specializes in the design, manufacture, and marketing of orthopedic reconstructive products, including knee and hip solutions. Additionally, it offers S.E.T. products, which cover a range of areas such as sports medicine, biologics, foot and ankle care, extremities, and trauma. The company also provides craniomaxillofacial and thoracic products, which are used in the reconstruction of the face and skull, as well as in the fixation and stabilization of chest bones, aiding in recovery or reconstruction following open heart surgery, trauma, or chest deformities. Furthermore, Zimmer Biomet offers robotic surgical systems and bone cement products. These products and solutions are designed to treat patients with disorders or injuries related to bones, joints, or supporting soft tissues. The company’s clients include orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents and healthcare purchasing organizations or buying groups. Originally known as Zimmer Holdings, Inc., the company rebranded to Zimmer Biomet Holdings, Inc. in June 2015. Founded in 1927, the company is headquartered in Warsaw, Indiana.
Zimmer Biomet Holdings Inc in the News:-
- 05-Sep-2024 - Zimmer Biomet Names David DeMartino as Senior Vice President, Investor Relations
- 29-Aug-2024 - Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2024
- 21-Aug-2024 - Zimmer Biomet to Present at the Wells Fargo 2024 and Morgan Stanley Annual Global Healthcare Conferences
- 07-Aug-2024 - Zimmer Biomet Announces Second Quarter 2024 Financial Results
- 07-Aug-2024 - Zimmer Biomet Signs Definitive Agreement to Acquire OrthoGrid Systems, Inc.
- Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
- Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
- Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
- Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
- Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.
- Comprehensive Understanding of the Zimmer Biomet Holdings Inc's internal and external factors through SWOT analysis, PESTLE analysis, Financial Analysis, and Competitors Benchmarking.
- Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
- Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
- Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
- Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
- Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
- Zimmer Biomet Holdings Inc Value Chain Analysis
- Zimmer Biomet Holdings Inc Porter's Five Forces Analysis
- Zimmer Biomet Holdings Inc VRIO Analysis
- Zimmer Biomet Holdings Inc BCG Analysis
- Zimmer Biomet Holdings Inc Segmentation, Targeting and Positioning (STP) Analysis
- Zimmer Biomet Holdings Inc Ansoff Matrix Analysis
Table of Contents
102 Pages
- COMPANY EXECUTIVE SUMMARY
- Table of Contents
- Tables
- Charts
- Zimmer Biomet Holdings Inc - Key Company Facts
- Zimmer Biomet Holdings Inc - Company Description
- Zimmer Biomet Holdings Inc - Top Executives
- Zimmer Biomet Holdings Inc- Head Office & Locations
- Head Office - Country
- Zimmer Biomet Holdings Inc - Products and Services
- Products
- Services
- Zimmer Biomet Holdings Inc - Company's Mission and Vision
- Mission
- Zimmer Biomet Holdings Inc - Corporate Strategy
- Zimmer Biomet Holdings Inc - Business Description
- Other Products (Robotics, Surgical, and Bone Cement Products)
- S.E.T. (Sports Medicine, Extremities, Trauma, and CMFT) Products
- Hip Products
- Knee Products
- Zimmer Biomet Holdings Inc - ESG Spotlight
- Environment
- Social
- Corporate Governance
- Zimmer Biomet Holdings Inc - SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Zimmer Biomet Holdings Inc - PESTLE Analysis
- Overview
- Political Factors
- Economic Factors
- Social Factors
- Technological Factors
- Legal Factors
- Environmental Factors
- Zimmer Biomet Holdings Inc - Financial Deep Dive
- Share Price Trend - Sep-2023to Sep-2024 (Average Share Closing Price)
- Profit and Loss Statement
- Summary of Profit and Loss Statement
- Balance Sheet
- Summary of Balance Sheet
- Cash Flow Statement
- Summary of Cash Flow Statement
- Key Financial Ratio Analysis
- Zimmer Biomet Holdings Inc - Ratio
- Charts
- Activity Ratio
- Charts
- Growth Ratios
- Charts
- Leverage Ratio
- Charts
- Liquidity Ratio
- Charts
- Profitability Ratio
- Charts
- Competing Players
- Snapshot of Competing Players
- Edwards Lifesciences Corporation
- Key Company Facts
- Company Description
- Snapshot of Competing Players
- Johnson & Johnson
- Key Company Facts
- Company Description
- Snapshot of Competing Players
- Medtronic plc
- Key Company Facts
- Company Description
- Snapshot of Competing Players
- Stryker Corporation
- Key Company Facts
- Company Description
- Snapshot of Competing Players
- Cook Medical Inc
- Key Company Facts
- Company Description
- Zimmer Biomet Holdings Inc - In the News
- 05-Sep-2024- Zimmer Biomet Names David DeMartino as Senior Vice President, Investor Relations
- 29-Aug-2024- Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2024
- 21-Aug-2024- Zimmer Biomet to Present at the Wells Fargo 2024 and Morgan Stanley Annual Global Healthcare Conferences
- 07-Aug-2024- Zimmer Biomet Announces Second Quarter 2024 Financial Results
- 07-Aug-2024- Zimmer Biomet Signs Definitive Agreement to Acquire OrthoGrid Systems, Inc.
- 08-Jul-2024- Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2024 Financial Results
- 20-Jun-2024- Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors
- 20-Jun-2024- Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors
- 20-Jun-2024- Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors
- 04-Jun-2024- Zimmer Biomet to Present at the Goldman Sachs 45th Annual Healthcare Conference
- 04-Jun-2024- Zimmer Biomet to Present at the Goldman Sachs 45th Annual Healthcare Conference
- 29-May-2024- Zimmer Biomet Outlines Strategy to Deliver Above Market Growth at 2024 Investor Day
- 20-May-2024- Zimmer Biomet Announces 2024 Investor Day
- 13-May-2024- Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2024
- 06-May-2024- Zimmer Biomet Publishes 2023 Sustainability Report
- 25-Apr-2024- Zimmer Biomet Announces Successful Completion of World's First Robotic-Assisted Shoulder Replacement Surgery with ROSA Shoulder System
- 22-Feb-2024- Zimmer Biomet Receives FDA Clearance for ROSA Shoulder System - the World's First Robotic Assistant for Shoulder Replacement Surgery
- 12-Feb-2024- Zimmer Biomet Showcases Latest Innovations Across Comprehensive Portfolio at AAOS 2024 Annual Meeting
- Zimmer Biomet Holdings Inc- Key Deals
- 07-Aug-2024 - Zimmer Biomet Signs Definitive Agreement to Acquire OrthoGrid Systems, Inc.
- 12-Jun-2024 - RevelAi Health and Zimmer Biomet Announce Exclusive Multi-Year Co-Marketing Agreement to Advance Value Based Care and Health Equity through AI-Powered Technology
- 12-Jun-2024 - RevelAi Health and Zimmer Biomet Announce Exclusive Multi-Year Co-Marketing Agreement to Advance Value Based Care and Health Equity through AI-Powered Technology
- 11-Jun-2024 - Zimmer Biomet Enters Distribution Agreement with THINK Surgical to Offer TMINI Miniature Handheld Robotic System for Total Knee Arthroplasty
- 11-Jun-2024 - Zimmer Biomet Enters Distribution Agreement with THINK Surgical to Offer TMINI Miniature Handheld Robotic System for Total Knee Arthroplasty
- 11-Jun-2024 - Zimmer Biomet Enters Distribution Agreement with THINK Surgical to Offer TMINI Miniature Handheld Robotic System for Total Knee Arthroplasty
- 04-Apr-2024 - Zimmer Biomet Becomes First and Only Official Medical Device Partner of Association of Pickleball Players, Professional Pickleball Association, and USA Pickleball
- Appendix
- Definitions
- SWOT Analysis
- PESTLE Analysis
- Value Chain Analysis
- ESG Spotlight
- Financial Deep Dive
- Financial Ratios -
- Activity Ratios
- Growth Ratios
- Leverage Ratios
- Liquidity Ratios
- Market Ratios
- Profitability Ratios
- Research Methodology
- Disclaimer
- Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.